» Articles » PMID: 32236624

A New Threat from an Old Enemy: Re‑emergence of Coronavirus (Review)

Abstract

The new outbreak of coronavirus from December 2019 has brought attention to an old viral enemy and has raised concerns as to the ability of current protection measures and the healthcare system to handle such a threat. It has been known since the 1960s that coronaviruses can cause respiratory infections in humans; however, their epidemic potential was understood only during the past two decades. In the present review, we address current knowledge on coronaviruses from a short history to epidemiology, pathogenesis, clinical manifestation of the disease, as well as treatment and prevention strategies. Although a great amount of research and efforts have been made worldwide to prevent further outbreaks of coronavirus‑associated disease, the spread and lethality of the 2019 outbreak (COVID‑19) is proving to be higher than previous epidemics on account of international travel density and immune naivety of the population. Only strong, joint and coordinated efforts of worldwide healthcare systems, researchers, and pharmaceutical companies and receptive national leaders will succeed in suppressing an outbreak of this scale.

Citing Articles

Nonhuman primate models of pediatric viral diseases.

Vijayan K K V, De Paris K Front Cell Infect Microbiol. 2024; 14:1493885.

PMID: 39691699 PMC: 11649651. DOI: 10.3389/fcimb.2024.1493885.


Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication.

Das S, Nath S, Shahjahan , Dey S Daru. 2024; 32(2):801-823.

PMID: 39026019 PMC: 11554973. DOI: 10.1007/s40199-024-00524-z.


[Perception of the risk of COVID-19, emotional intelligence and psychological health of caregivers].

Tagne Nossi A, Tachom Waffo B, Ngah Essomba H, Mvessomba E Eur J Trauma Dissociation. 2024; 5(2):100212.

PMID: 38620718 PMC: 8012170. DOI: 10.1016/j.ejtd.2021.100212.


Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units.

Genc S, Taghizadehghalehjoughi A, Naldan M, Gulcu O, Caglayan C, Spanakis M Exp Ther Med. 2024; 27(2):82.

PMID: 38274343 PMC: 10809360. DOI: 10.3892/etm.2024.12371.


Graduate and postgraduate educational challenges during the COVID-19 pandemic period: its impact and innovations-a scoping review.

Shoaib M, Sikandar M, Yousuf R, Parkash M, Kazmi S, Ahmed F Syst Rev. 2023; 12(1):195.

PMID: 37833820 PMC: 10571448. DOI: 10.1186/s13643-023-02359-2.


References
1.
Hui D, Sung J . Severe acute respiratory syndrome. Chest. 2003; 124(1):12-5. PMC: 7130151. DOI: 10.1378/chest.124.1.12. View

2.
Widagdo W, Okba N, Raj V, Haagmans B . MERS-coronavirus: From discovery to intervention. One Health. 2017; 3:11-16. PMC: 5454172. DOI: 10.1016/j.onehlt.2016.12.001. View

3.
Ng D, Al Hosani F, Keating M, Gerber S, Jones T, Metcalfe M . Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014. Am J Pathol. 2016; 186(3):652-8. PMC: 7093852. DOI: 10.1016/j.ajpath.2015.10.024. View

4.
Livingston E, Bucher K . Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020; 323(14):1335. DOI: 10.1001/jama.2020.4344. View

5.
Lin X, Gong Z, Xiao Z, Xiong J, Fan B, Liu J . Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases. Korean J Radiol. 2020; 21(3):365-368. PMC: 7039714. DOI: 10.3348/kjr.2020.0078. View